TOP ASX Growth Stocks To Watch: April 2022 📈 (LKE, LRS, IMU)

TL;DR

Get ready for April as we explore three ASX stocks to watch, including Latin Resources, Imogene, and Lake Resources, with Tesla considering a second stock split.

Transcript

march is coming to an end and with it the first quarter of 2022 is in the books and we can look ahead to april and a new chapter the first period in 2022 has been a fascinating one we came into the year with momentum but of course there was a global sell down with corrections across many of the leading global indices we've had geopolitical tensions... Read More

Key Insights

• 👇 The first quarter of 2022 has been eventful, with global sell-downs, geopolitical tensions, inflation uncertainties, and interest rate concerns affecting the leading global indices.
• ✋ Latin Resources is positioned for growth with significant drilling results for high-grade lithium, while Imogene continues to make progress in its biotech endeavors across research, clinical trials, and potential commercial agreements.
• 🏛️ Lake Resources is focused on building a strategic and sustainable supply chain for its lithium project, as demonstrated by the Memorandum of Understanding with Hanwa.
• 😮 Tesla's consideration of a second stock split speaks to the rapid rise in its share price and aims to increase liquidity and public perception, but does not impact the fundamental value of the shares.
• 🇪🇺 The opening of Tesla's Giga Berlin manufacturing facility in Europe marks an important milestone for the company and the growing European electric vehicle market. However, the supply of raw materials for EVs may lag behind the increasing demand.

Questions & Answers

Q: Why is Latin Resources gaining attention in the market?

Latin Resources has recently released high-grade lithium drilling results, sparking interest among investors. These results show promising potential for their exploration projects and future resource development.

Q: What progress has Imogene made in terms of clinical development?

Imogene has reached a significant milestone in their phase one clinical trial for their viral therapy, CheckVAC, by proving its safety and lack of adverse reactions. They have also obtained ethics approval to start a phase one clinical trial for their oncolytic viral therapy, VACinia, in the USA.

Q: What is Lake Resources' latest milestone?

Lake Resources has signed a memorandum of understanding with Hanwa, a Japanese company, to negotiate an off-take agreement for their Kachi lithium project. This indicates their focus on establishing a long-term strategic partnership and sustainable supply chain.

Q: Why is Tesla considering a second stock split?

Tesla has requested approvals for a second stock split, potentially increasing liquidity and public perception. Stock splits do not affect the overall value of holdings but can impact sentiment and accessibility for investors.

Summary & Key Takeaways

• Latin Resources (ASX: LRS) is an early stage exploration company with assets in Latin America and Australia, attracting attention with significant drilling results for high-grade lithium.

• Imogene (ASX: IMU) has been a top performer in the biotech industry and continues to progress with developments across research and development, clinical trials, and potential commercial agreements.

• Lake Resources (ASX: LKE) is making strides with a memorandum of understanding for an off-take agreement with Hanwa, highlighting their commitment to a strategic and sustainable supply chain for their lithium project.